2008
DOI: 10.1016/j.ajog.2008.06.085
|View full text |Cite
|
Sign up to set email alerts
|

Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
66
0
7

Year Published

2009
2009
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 85 publications
(75 citation statements)
references
References 25 publications
2
66
0
7
Order By: Relevance
“…Several studies demonstrated that progesterone promotes myometrial relaxation. [43][44][45] Our finding that the absence of C5aR prevents PTD in the mouse models has important therapeutic implications. Blocking the complement cascade at C5a and CaR interaction inhibits mediators and effectors of cervical remodeling and prevents PTD, suggesting that complement might be a good target for therapy in women with PTD.…”
Section: Discussionmentioning
confidence: 99%
“…Several studies demonstrated that progesterone promotes myometrial relaxation. [43][44][45] Our finding that the absence of C5aR prevents PTD in the mouse models has important therapeutic implications. Blocking the complement cascade at C5a and CaR interaction inhibits mediators and effectors of cervical remodeling and prevents PTD, suggesting that complement might be a good target for therapy in women with PTD.…”
Section: Discussionmentioning
confidence: 99%
“…9 In contrast, 17HPC did not bring a direct relaxant effect on human myometrium in vitro, 9,10 and in high concentrations stimulated the uterine tissue contractile activity. 9 One of the explanations offered by the authors for the nul or stimulating effect of 17HPC was the use of myometrium tissue samples obtained from women undergoing cesarean section late in pregnancy 9,10 and from nonpregnant participants, 10 rather than preterm myometrium, which could display a different responsiveness to 17HPC. Furthermore, Sexton and coauthors suggested that in vivo administration of 17HPC could result in the formation of a metabolite exerting an uterorelaxant effect.…”
Section: Discussionmentioning
confidence: 99%
“…Clinically, progesterone is the only agent shown to be effective in preventing preterm birth with efficacy proven for selected groups (Dodd et al 2008). The mechanism of action of progesterone is unknown, although there is some evidence in vitro of an acute inhibitory effect on myometrial contractions (Ruddock et al 2008). Progestogens may also act to inhibit inflammation, with inhibition of LPS-induced inflammation in human fetoplacental arteries and in myometrium (Gotkin et al 2006) and inhibition of a Inflammation in reproductive processes physiological rise in mouse myometrial CCL2 in vivo (Shynlova et al 2008).…”
Section: Complicated Labourmentioning
confidence: 99%